Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

Historical Holders from Q1 2023 to Q3 2025

Type / Class
Equity / Ordinary Shares, no par value
Symbol
CANF on NYSE
Shares outstanding
3,838,602,439
Price per share
$0.6192
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
1,538,481
Holdings value
$952,611
% of all portfolios
0%
Share change
+634,597
Value change
+$392,864
Average buys %
+0%
Average sells %
-0%
Number of holders
15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Orca Capital AG 4.1% -56% $220,335,780 -$304,664,220 157,382,700 -58% Orca Capital AG 22 Apr 2025
ARMISTICE CAPITAL, LLC 5% $616,591 440,422 Armistice Capital, LLC 31 Dec 2024
As of 30 Sep 2025, Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) has 15 institutional shareholders filing 13F forms. They hold 1,538,481 shares of 3,838,602,439 outstanding shares (0.04%) .

Institutional Holders of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,538,481 $952,611 +$392,864 $0.6192 15
2025 Q2 904,884 $950,122 +$805,186 $1.05 15
2025 Q1 131,231 $193,878 +$24,967 $1.48 13
2024 Q4 114,427 $185,941 -$1,330,864 $1.62 13
2024 Q3 754,233 $1,516,004 +$242,710 $2.01 11
2024 Q2 627,823 $1,619,070 +$392,788 $2.58 11
2024 Q1 477,583 $1,060,150 +$498,205 $2.22 8
2023 Q4 243,810 $536,298 +$352,892 $2.20 8
2023 Q3 67,589 $178,991 +$34,520 $2.65 7
2023 Q2 54,562 $167,509 -$705,135 $3.07 5
2023 Q1 368,274 $843,323 +$843,323 $2.29 6